Finally, just as combinations of CFTR correctors have proved decisive in restoring the plasma membrane expression and stability of mutant CFTR [83], the identification of potent efficacious potentiator combinations [73,74,76,81] heralds a strategy to restore wild-type levels of activity to CF mutants. The gene discussed is CFTR; the disease is cystic fibrosis.